1Chatzizacharias NA, Kouraklis GP, Theocharis SE. Clinical significance of FAK expression in human neoplasia[J].Histol Histopathol,2008,23(5) :629-650.
2Colombo N, Van Gorp T, Parma G,et al. Ovarian cancer [J]. Crit Rev Oncol Hematol,2006, 60(2):159- 179.
3Grisaru Granovsky S, Salah Z, Maoz M,et al. Differential expression of protease activated receptor 1 (Parl) and pY397FAK in benign and malignant human ovarian tissue samples[J]. Int J Cancer, 2005,113(3) :372- 338.
4Wang X, Urvalek AM, Liu J, et al. Activation of KLF8 transcription by focal adhesion kinase in human ovarian epithelial and cancer cells[J]. J Biol Chem, 2008,283(20) : 13934-13942.
5Yoshida H, Liu J, Samuel S, et al. Steroid receptor coactivator-3, a homolog of Taiman that controls cell migration in the Drosophila ovary, regulates migration of human ovarian cancer cells [J]. Mol Cell Endocrinol,2005,245(1-2):77-85.
6Aponte M, Jiang W, Lakkis M,et al. Activation of platelet-activating factor receptor and pleiotropie effects on tyrosine phospho-EGFR/Src/FAK/paxillin in ovarian cancer[J]. Cancer Res,2008, 68(14) :5839- 5848.
7Ponnusamy MP, Singh AP, Jain M, etal. MUC4 activates HER2 signalling and enhances the motility of human ovarian cancer cells [J]. BrJ Cancer,2008,99(3):520-526.
8Bian D, Su S, Mahanivong C,et al. Lysophosphatidic Acid Stimulates Ovarian Cancer Cell Migration via a Ras-MEK Kinase 1 Pathway[J]. Cancer Res, 2004,64(12) :4209-4217.
10Villedieu M, Deslandes E, Duval M, et al. Acquisition of chemoresistance following discontinuous exposures to eisplatin is as sociated in ovarian carcinoma ceils with progressive alteration of FAK, ERK and p38 activation in response to treatment[J]. Gynecol Oncol, 2006,101(3) :507-519.
4NakagawaH,Kiyozuka Y,Vemura Y,et al.Resveratrol inhibits human breast cancer cell growth and may mitigate the effect of linoleic acid,a potent breast cancer cell stimulator[J].J Cancer ResClin Oncol,2001,127(4):258-64.
5Xu S H,Qian L J,Hanzhou N,et al.Establishment of a highly metastatic human ovarian cancer cell line(HO-8910PM)and its characterization[J].J Exp Clin Cancer Res,1999,18(2):233-9.
6Cohen L A,Guan J L.Mechanisms of focal adhesion kinase regulation[J].Curr Cancer Drug Targets,2005,5(8):629-43.
7Hess A R,Hendrix M J.Focal adhesion kinase signaling and the aggressive melanoma phenotype[J].Cell Cycle,2006,5(5):478-80.
8Furuyama K,Doi R,Mori T,et al.Clinical significance of focal adhesion kinase in resectable pancreatic cancer[J].World J Surg,2006,30(2):219-26.
9Hsia D A,Mitra S K,Hauck C R,et al.Differential regulation of cell motility and invasion by FAK[J].J Cell Biol,2003,160(5):753-67.
10Miyazaki T,Kato H,Nakajima M,et al.FAK overexpression is correlated with tumour invasiveness and lymph node metastasis in oesophageal squamous cell carcinoma[J].Br J Cancer,2003,89(1):140-5.
